8-K: DENTSPLY SIRONA Appoints Michael Pomeroy Interim CFO

DENTSPLY SIRONA Inc. announced the appointment of Michael Pomeroy as interim Chief Financial Officer, effective November 25, 2025, while the search for a permanent CFO continues.

Summary

• DENTSPLY SIRONA Inc. appointed Michael Pomeroy as interim Chief Financial Officer, effective November 25, 2025.
• Mr. Pomeroy will serve in this temporary capacity until a permanent Chief Financial Officer is identified and appointed.
• Daniel T. Scavilla, President and Chief Executive Officer, will continue to serve as the principal financial officer in addition to his principal executive officer role.
• Mr. Pomeroy brings extensive finance leadership experience from various industries, including healthcare, and has a background in growth, turnaround, operational improvement, and M&A activities.
• His recent roles include interim CFO of Highridge Medical (February 2025 to September 2025) and CFO positions at Icahn Automotive Group (2022-2024), Hollander-Keeco (2021-2022), and RGIS (2017-2021).

Sentiment

Score: 6

Explanation: The appointment of an experienced interim CFO provides stability and continuity, which is positive. However, the interim nature of the role introduces a slight element of uncertainty as the search for a permanent CFO continues.

Positives

• The appointment of Michael Pomeroy, an experienced finance leader, ensures continuity in the critical CFO role during the transition period.
• Mr. Pomeroy's background includes successful growth, turnaround, operational improvement, and M&A activities across diverse industries, including healthcare, which is beneficial for the company.
• Daniel T. Scavilla, President and CEO, will maintain oversight as principal financial officer, providing additional stability during the interim period.

Negatives

• The appointment is temporary, indicating that a permanent Chief Financial Officer has not yet been secured, which could introduce a degree of uncertainty regarding long-term financial leadership.

Future Outlook

The company is actively searching for a permanent Chief Financial Officer, indicating a future transition in the finance leadership role.

Management Comments

• Daniel T. Scavilla, President and Chief Executive Officer, will continue to serve as the company's principal financial officer (in addition to serving as the company's principal executive officer) until a permanent Chief Financial Officer is identified and appointed.

Industry Context

The appointment of an interim CFO is a common practice in the healthcare and dental equipment industry when a permanent executive search is underway, ensuring operational continuity and financial oversight during transitions. Michael Pomeroy's prior experience in healthcare (Highridge Medical) is relevant to the industry.

Management Changes

Stakeholder Impact

• Shareholders: Provides continuity in financial leadership during a transition period, potentially reducing uncertainty.
• Employees: Ensures stable financial oversight.
• Management: Daniel T. Scavilla receives support in his principal financial officer duties from the interim CFO.

Next Steps

• Identify and appoint a permanent Chief Financial Officer.

Key Dates

Recommendation

The appointment of an experienced interim CFO provides stability and ensures continuity in financial operations during the search for a permanent executive. This move mitigates immediate leadership gaps but does not introduce new strategic direction or significant financial performance indicators that would warrant a strong buy or sell recommendation. Investors should hold and monitor for the announcement of a permanent CFO and any associated strategic shifts.

Keywords

DENTSPLY SIRONA, XRAY, CFO, Chief Financial Officer, Michael Pomeroy, Interim CFO, Executive Appointment, Corporate Governance, Financial Leadership, Healthcare Industry